Although both parents and pediatricians understand the need to treat kids with hypertension, few believe the diagnosis or ...

As the awareness of hypertension grows, exploring alternative and complementary therapies like yoga becomes increasingly ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines for blood pressure coexist, emanating from European,1,2 North American,3 ...

Stress has so many avatars, that one needs to reach the root cause of its occurrence on a bio-individual level. And also, ...

DESPITE the common misconception that hypertension has no symptoms, a heart specialist, Dr Akinyemi Aje, has stated that ...

Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Experiencing microaggressions based on gender and race while receiving care during pregnancy and delivery may be linked to ...

The action affects the TROPOS trial of cibotacept (KER-012), an activin signalling inhibitor that works in a similar way to ...

Taken together with Keros’ recent pivot away from obesity, the termination of its pulmonary arterial hypertension study could ...